NIR analysis of cellulose and lactose—Application to ecstasy tablet analysis
Authors:
- Ines BaerIBInes Baer
- Robert GurnyRGRobert Gurny
- Pierre MargotPMPierre Margot
- 1 April 2007
- journal article
- Published by Elsevier in Forensic Science International
- Vol. 167 (2-3) , 234-241
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Influence of Ambient Moisture on the Compaction Behavior of Microcrystalline Cellulose Powder Undergoing Uni-Axial Compression and Roller-Compaction: A Comparative Study Using Near-Infrared SpectroscopyJournal of Pharmaceutical Sciences, 2005
- Characterizing process effects on pharmaceutical solid forms using near-infrared spectroscopy and infrared imagingEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Application of near-infrared spectroscopy to the determination of the sites of manufacture of proprietary productsJournal of Pharmaceutical and Biomedical Analysis, 2004
- Quantitative determination of crystallinity of alpha-lactose monohydrate by Near Infrared Spectroscopy (NIRS)International Journal of Pharmaceutics, 2003
- Chemical Image Fusion. The Synergy of FT-NIR and Raman Mapping Microscopy To Enable a More Complete Visualization of Pharmaceutical FormulationsAnalytical Chemistry, 2001
- One hundred percent online identity check of pharmaceutical products by near-infrared spectroscopy on the packaging lineEuropean Journal of Pharmaceutics and Biopharmaceutics, 2001
- Application of NIR reflectance spectroscopy for the identification of pharmaceutical excipientsAnalytica Chimica Acta, 2000
- In-line moisture measurement during granulation with a four-wavelength near infrared sensor: an evaluation of particle size and binder effectsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- The use of near infra-red spectroscopy to detect changes in the form of amorphous and crystalline lactoseInternational Journal of Pharmaceutics, 1998
- Optimisation of sample presentation for the near-infrared spectra of pharmaceutical excipients†The Analyst, 1998